Sienna Biopharmaceuticals, Inc. Insider Trading for August 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sienna Biopharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Sienna Biopharmaceuticals, Inc. for August 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Andrews Timothy K. | General Counsel & S ... | Option Exercise | A | 0.71 | 22,500 | 15,975 | 22,500 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Andrews Timothy K. | General Counsel & S ... | Option Exercise | A | 0.71 | 22,500 | 15,975 | 22,500 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Andrews Timothy K. | General Counsel & S ... | Option Exercise | A | 0.71 | 18,290 | 12,986 | 18,290 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Andrews Timothy K. | General Counsel & S ... | Option Exercise | A | 0.71 | 60,000 | 42,600 | 60,000 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Andrews Timothy K. | General Counsel & S ... | Option Exercise | A | 0.71 | 8,518 | 6,048 | 8,518 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Andrews Timothy K. | General Counsel & S ... | Option Exercise | D | 2.32 | 22,500 | 52,200 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Andrews Timothy K. | General Counsel & S ... | Option Exercise | D | 2.32 | 22,500 | 52,200 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Andrews Timothy K. | General Counsel & S ... | Option Exercise | D | 2.32 | 18,290 | 42,433 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Andrews Timothy K. | General Counsel & S ... | Option Exercise | D | 15.00 | 8,518 | 127,770 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Andrews Timothy K. | General Counsel & S ... | Option Exercise | D | 15.08 | 60,000 | 904,800 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Andrews Timothy K. | General Counsel & S ... | Grant | A | 0.00 | 50,000 | 0 | 145,558 | 95.6 K to 145.6 K (+52.32 %) |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Option Exercise | A | 0.71 | 20,000 | 14,200 | 20,000 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Option Exercise | A | 0.71 | 8,750 | 6,213 | 8,750 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Option Exercise | A | 0.71 | 8,750 | 6,213 | 8,750 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Option Exercise | A | 0.71 | 5,600 | 3,976 | 5,600 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Option Exercise | A | 0.71 | 25,000 | 17,750 | 25,000 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Option Exercise | D | 2.32 | 8,750 | 20,300 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Option Exercise | D | 2.32 | 8,750 | 20,300 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Option Exercise | D | 2.37 | 20,000 | 47,400 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Option Exercise | D | 15.08 | 5,600 | 84,448 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Option Exercise | D | 20.19 | 25,000 | 504,750 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Grant | A | 0.00 | 70,000 | 0 | 105,948 | 35.9 K to 105.9 K (+194.73 %) |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Lizzul Paul F. | Chief Medical Offic ... | Option Exercise | A | 0.71 | 22,500 | 15,975 | 22,500 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Lizzul Paul F. | Chief Medical Offic ... | Option Exercise | A | 0.71 | 22,500 | 15,975 | 22,500 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Lizzul Paul F. | Chief Medical Offic ... | Option Exercise | A | 0.71 | 14,904 | 10,582 | 14,904 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Lizzul Paul F. | Chief Medical Offic ... | Option Exercise | A | 0.71 | 48,720 | 34,591 | 48,720 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Lizzul Paul F. | Chief Medical Offic ... | Option Exercise | A | 0.71 | 11,926 | 8,467 | 11,926 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Lizzul Paul F. | Chief Medical Offic ... | Option Exercise | D | 2.32 | 22,500 | 52,200 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Lizzul Paul F. | Chief Medical Offic ... | Option Exercise | D | 2.32 | 22,500 | 52,200 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Lizzul Paul F. | Chief Medical Offic ... | Option Exercise | D | 2.32 | 14,904 | 34,577 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Lizzul Paul F. | Chief Medical Offic ... | Option Exercise | D | 15.00 | 11,926 | 178,890 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Lizzul Paul F. | Chief Medical Offic ... | Option Exercise | D | 15.08 | 48,720 | 734,698 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Lizzul Paul F. | Chief Medical Offic ... | Grant | A | 0.00 | 55,000 | 0 | 196,488 | 141.5 K to 196.5 K (+38.87 %) |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Beddingfield III Frederick | President & CEO | Option Exercise | A | 0.71 | 93,750 | 66,563 | 93,750 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Beddingfield III Frederick | President & CEO | Option Exercise | A | 0.71 | 93,750 | 66,563 | 93,750 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Beddingfield III Frederick | President & CEO | Option Exercise | A | 0.71 | 40,968 | 29,087 | 40,968 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Beddingfield III Frederick | President & CEO | Option Exercise | A | 0.71 | 190,910 | 135,546 | 190,910 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Beddingfield III Frederick | President & CEO | Option Exercise | A | 0.71 | 42,590 | 30,239 | 42,590 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Beddingfield III Frederick | President & CEO | Option Exercise | D | 2.32 | 93,750 | 217,500 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Beddingfield III Frederick | President & CEO | Option Exercise | D | 2.32 | 93,750 | 217,500 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Beddingfield III Frederick | President & CEO | Option Exercise | D | 2.32 | 40,968 | 95,046 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Beddingfield III Frederick | President & CEO | Option Exercise | D | 15.00 | 42,590 | 638,850 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Beddingfield III Frederick | President & CEO | Option Exercise | D | 15.08 | 190,910 | 2,878,923 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Beddingfield III Frederick | President & CEO | Grant | A | 0.00 | 150,000 | 0 | 967,599 | 817.6 K to 967.6 K (+18.35 %) |